High serum titers of neutralizing antibodies develop in a small fraction of people who become infected with HIV-1. Isolation of such broadly neutralizing antibodies (bNAbs) has led to a new and promising approach to combat HIV-1 infection.
No takes yet. Share an insight, caveat, or question.
Caskey et al. (2016) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: